Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ATRX |
| Variant | negative |
| Impact List | unknown |
| Protein Effect | loss of function |
| Gene Variant Descriptions | ATRX negative indicates a lack of expression of the ATRX mRNA and/or protein. |
| Associated Drug Resistance | |
| Category Variants Paths |
ATRX mutant ATRX inact mut ATRX negative |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05303519 | Phase III | DS-1001b | SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) (SIGMA) | Recruiting | USA | AUS | 1 |
| NCT03893903 | Phase I | Avelumab IDH1 R132H peptide vaccine Avelumab + IDH1 R132H peptide vaccine | AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (AMPLIFY-NEOVAC) | Completed | DEU | 0 |